Stocks to Watch: Oracle, Mission Produce, CytomX Therapeutics
By Dean Seal
Oracle said revenue rose in its fiscal third quarter on strong demand for cloud services, powered in part by growing interest in generative artificial intelligence. Shares jumped 13% to $129.25 in after-hours trading.
Mission Produce broke even in its fiscal first quarter as higher avocado prices boosted sales 21%. Shares climbed 5.9% to $11.33 in post-market trading.
CytomX Therapeutics said that after an internal portfolio review, Bristol Myers Squibb has decided not to advance its candidate BMS-986288 as part of a research collaboration between the companies. CytomX shares were down 23% at $1.94 in after-market trading.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
March 11, 2024 18:55 ET (22:55 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom